EconPapers    
Economics at your fingertips  
 

The development and use of antiprogestin drugs: Social, political, economic, and legal issues: Medicine in the Public Interest, Boston, 1992 49 pp., US$5

M. De Wachter

Health Policy, 1993, vol. 25, issue 3, 272-273

Date: 1993
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/0168-8510(93)90021-G
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:25:y:1993:i:3:p:272-273

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().

 
Page updated 2025-03-19
Handle: RePEc:eee:hepoli:v:25:y:1993:i:3:p:272-273